5-hydroxytryptophan has been researched along with clozapine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, L; Papousek, M; Reichinger, M; Reiter, H; Rudolph, M; Rüther, E | 1 |
| Audinot, V; Gobert, A; Lejeune, F; Millan, MJ; Rivet, JM; Spedding, M | 1 |
| Fienberg, AA; Greengard, P; Liu, F; Nomikos, GG; Svenningsson, P; Tzavara, ET | 1 |
| Ninan, I; Wang, RY | 1 |
| Gibert-Rahola, J; Mico, JA; Rojas-Corrales, MO | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Deng, X; Fu, W; Guo, L; Xu, L; Yu, K; Zhao, W; Zhen, X | 1 |
7 other study(ies) available for 5-hydroxytryptophan and clozapine
| Article | Year |
|---|---|
[Pharmacological influence on central serotonergic mechanisms in man and its consequences on sleep (author's transl)].
Topics: 5-Hydroxytryptophan; Adult; Benserazide; Brain; Clozapine; Female; Humans; Male; Methamphetamine; Middle Aged; Serotonin; Sleep | 1976 |
Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Clozapine; Electrophysiology; Male; Neurons; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Purinergic P1; Receptors, Serotonin; Serotonin; Synaptic Transmission | 1994 |
DARPP-32 mediates serotonergic neurotransmission in the forebrain.
Topics: 5-Hydroxytryptophan; Animals; Brain; Cerebral Cortex; Clozapine; Culture Techniques; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Nerve Tissue Proteins; p-Chloroamphetamine; Phosphoproteins; Phosphorylation; Prosencephalon; Serotonin; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction | 2002 |
Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence.
Topics: 5-Hydroxytryptophan; alpha-Methyltyrosine; Animals; Antipsychotic Agents; Benzazepines; Clozapine; Dopamine; Dopamine Agents; Dopamine Antagonists; Electric Stimulation; Electrophysiology; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glutamic Acid; Levodopa; Male; N-Methylaspartate; Prefrontal Cortex; Pyramidal Cells; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reserpine; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2003 |
Role of atypical opiates in OCD. Experimental approach through the study of 5-HT(2A/C) receptor-mediated behavior.
Topics: 5-Hydroxytryptophan; Analgesics, Opioid; Animals; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Indophenol; Levorphanol; Male; Methadone; Mice; Morphine; Naloxone; Narcotic Antagonists; Obsessive-Compulsive Disorder; Piperazines; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Stereotyped Behavior; Tics; Tourette Syndrome; Tramadol; Triazoles | 2007 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Discovery of novel potent and selective ligands for 5-HT2A receptor with quinazoline scaffold.
Topics: Dose-Response Relationship, Drug; Drug Discovery; Humans; Ligands; Molecular Structure; Quinazolines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship | 2015 |